Why one doctor says the DEA shouldn't mine Oregon's trove of painkiller data
Oregon doctors wrote nearly 3 million prescriptions in 2014 for hydrocodone and oxycodone, the top two narcotic painkillers, according to the Oregon Prescription Drug Monitoring Program's report for the year. Pharmacists and providers made 800,000 queries to the database, showing that it's become a useful tool for prescribers to screen patients and identify possible abuse. But Oregon doctors are concerned about three particular requests for information that were made last year. That's because they… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 16, 2015 Category: Biotechnology Authors: Elizabeth Hayes Source Type: news

Report highlights the dangers of opioid painkillers
Whenever I read or write about the overuse of so-called opioid painkillers it is with mixed feelings. As a lifelong back-pain patient who once depended on them for pain relief, I appreciate the challenge posed by opioids to people in pain and their doctors. People in agonizing pain want it to stop, but opioids are often a poor long-term solution. Doctors want to help their patients, so they may prescribe opioids for extended periods despite well-founded reservations. At the same time, the epidemic of abuse of these painkillers has led to numerous deaths. Like many Americans, I know people whose lives were destroyed—w...
Source: New Harvard Health Information - January 15, 2015 Category: Consumer Health News Authors: Daniel Pendick Tags: Addiction Drugs and Supplements Pain Management hydrocodone opioids oxycodone Source Type: news

The 5th Annual Alexander Awards: The Best Tox Reading of 2014
Alexander Gettler The distinguished Alexander Awards go to the best writings related to toxicology topics that have appeared in the previous year. To be eligible to win an Alexander, an article or paper must be freely available on the web, not locked up behind some paywall or subject to restricted access. The awards are named for Alexander Gettler (1883-1968,) the chief toxicologist with the Office of the Chief Medical Examiner of the City of New York during the first half of the 20th century. Gettler’s work was crucial in the development of modern forensic toxicology. In a must-read piece from New York&nbs...
Source: The Poison Review - January 2, 2015 Category: Toxicology Authors: Leon Tags: Medical alexander award alexander gentler best toxicology reading 2014 Source Type: news

Addiction Is a Disease That Shatters Lives -- It's Time to Say ENOUGH #WeAreShatterproof
I know how terrible the disease of addiction can be. Three years ago, my son Brian -- 15 months clean but unable to handle the shame and stigma of his disease -- took his own life. He was just 25 years old. He had struggled with addiction for nearly a decade and tried time and again to get clean and stay healthy. But addiction is a dark and lonely road for those who walk it. Brian's death shattered my family, and tragically we are not alone. Our story is shared by hundreds of thousands of other parents across the country. Every day, about 22 million Americans struggle with addiction, and it's only getting worse. Fatal ...
Source: Healthy Living - The Huffington Post - December 23, 2014 Category: Consumer Health News Source Type: news

Obredon (Hydrocodone Bitartrate and Guaifenesin Oral Solution) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 9, 2014 Category: Drugs & Pharmacology Source Type: news

Hysingla ER (Hydrocodone Bitartrate Extended-release Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 3, 2014 Category: Drugs & Pharmacology Source Type: news

Price of Addiction: Is this newly approved pain pill actually smarter?
The U.S. Food & Drug Administration on Thursday approved a "smart" opioid prescription painkiller that is supposed to be more difficult to abuse. Hysingla ER is an extended-release hydrocodone tablet that's difficult to crush, break or dissolve, and therefore, harder to snort or inject. The approval comes at a time that prescription opioid abuse has reached epidemic levels in Oregon and across the U.S. Price of addiction: Read more stories in our series. Dr. David Russo, a pain management… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - November 21, 2014 Category: American Health Authors: Elizabeth Hayes Source Type: news

Price of Addiction: Is this newly approved pain pill actually smarter?
The U.S. Food & Drug Administration on Thursday approved a "smart" opioid prescription painkiller that is supposed to be more difficult to abuse. Hysingla ER is an extended-release hydrocodone tablet that's difficult to crush, break or dissolve, and therefore, harder to snort or inject. The approval comes at a time that prescription opioid abuse has reached epidemic levels in Oregon and across the U.S. Price of addiction: Read more stories in our series. Dr. David Russo, a pain management… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 21, 2014 Category: Biotechnology Authors: Elizabeth Hayes Source Type: news

FDA Okays Abuse-Deterrent Hydrocodone
(MedPage Today) -- But abuse risks remain, agency and experts warn. (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - November 21, 2014 Category: Psychiatry Source Type: news

F.D.A. Approves Hysingla, a Powerful Painkiller
The Food and Drug Administration on Thursday approved a long-acting opioid painkiller that contains pure hydrocodone, which some addiction experts fear will be abused. (Source: NYT Health)
Source: NYT Health - November 21, 2014 Category: Consumer Health News Authors: By RONI CARYN RABIN Tags: Pain-Relieving Drugs Hysingla Drugs (Pharmaceuticals) Drug Abuse and Traffic Food and Drug Administration Zohydro (Drug) Source Type: news

FDA Clears Hydrocodone With Abuse-Deterrent Properties FDA Clears Hydrocodone With Abuse-Deterrent Properties
The physical and chemical properties of single-entity Hysingla ER (Purdue Pharma) are expected to make abuse difficult, the FDA says. FDA Approvals (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - November 21, 2014 Category: Emergency Medicine Tags: Neurology & Neurosurgery News Source Type: news

FDA approves new opioid painkiller said to last 24 hours
Federal regulators gave the green light to a once-a-day opioid pain-relief pill that is up to 24 times more powerful than a single Vicodin but is designed to thwart the immediate release of its full — and potentially lethal — payload. (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - November 21, 2014 Category: Science Source Type: news

FDA Approves Harder-to-Abuse Hydrocodone (FREE)
By Kristin J. Kelley Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS Hydrocodone bitartrate (marketed as Hysingla ER) has been approved by the FDA for treating chronic, "around-the-clock" pain in … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - November 21, 2014 Category: Primary Care Source Type: news

FDA Approves 'Abuse-Resistant' Narcotic Painkiller
Agency says it's latest step in curbing epidemic of addiction to drugs such as Oxycontin, Vicodin (Source: WebMD Health)
Source: WebMD Health - November 20, 2014 Category: Consumer Health News Source Type: news

FDA Approves 'Abuse-Resistant' Narcotic Painkiller
Agency says it's latest step in curbing epidemic of addiction to drugs such as Oxycontin, Vicodin Source: HealthDay Related MedlinePlus Pages: Pain Relievers, Prescription Drug Abuse (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - November 20, 2014 Category: Consumer Health News Source Type: news

FDA Approves Hydrocodone Product for Treating Severe Pain
FDA approves Hysingla ER, an extended-release opioid analgesic with abuse-deterrent properties to treat pain severe enough to require around-the-clock, long-term opioid treatment (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 20, 2014 Category: Pharmaceuticals Source Type: news

FDA approves extended-release, single-entity hydrocodone product with abuse-deterrent properties
The U.S. Food and Drug Administration today approved Hysingla ER (hydrocodone bitartrate), an extended-release (ER) opioid analgesic to treat pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. Hysingla ER has approved labeling describing the product’s abuse-deterrent properties consistent with the FDA’s 2013 draft guidance for industry, Abuse-Deterrent Opioids – Evaluation and Labeling. (Source: Food and Drug Administration)
Source: Food and Drug Administration - November 20, 2014 Category: American Health Source Type: news

Hydrocodone Reclassification Fuels Sharp Increase in Demand for Kirby...
The U.S. Drug Enforcement Agency’s (DEA) reclassification of hydrocodone combination products to Schedule II resulted in a significant increase in demand for Kirby Lester KL1 and KL1Plus tablet...(PRWeb November 11, 2014)Read the full story at http://www.prweb.com/releases/2014/11/prweb12314716.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 11, 2014 Category: Pharmaceuticals Source Type: news

Data Support FDA Restrictions on Child Cough and Cold Medicines
Surveillance data showed more adverse events for children exposed to hydrocodone than codeine (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - November 11, 2014 Category: Respiratory Medicine Tags: Family Medicine, Nursing, Pediatrics, Pharmacy, Pulmonology, Emergency Medicine, Journal, Source Type: news

Top 10 Most Prescribed Generic Drugs through SeptemberTop 10 Most Prescribed Generic Drugs through September
The pain medication hydrocodone/acetaminophen was the most prescribed generic drug for the 12 months ending September 30, 2014, followed by the blood pressure drug lisinopril, according to a new report. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 7, 2014 Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news

Celia Walden on the pain of going teetotal
From Vicodin to Valium, no amount of prescription drugs can ease Celia Walden's agony at laying off the booze (Source: Telegraph Health)
Source: Telegraph Health - October 23, 2014 Category: Consumer Health News Tags: prescription drugs ambien valium wine wine and painkillers piers morgan los angeles celia walden california vicodin Source Type: news

Small Change in Opioid Prescribing Will Have Big ImpactSmall Change in Opioid Prescribing Will Have Big Impact
Moving hydrocodone combination products to Schedule II among controlled substances will lead to many adjustments from doctors and patients. Medscape Business of Medicine (Source: Medscape Business of Medicine Headlines)
Source: Medscape Business of Medicine Headlines - October 22, 2014 Category: Pharmaceuticals Tags: Family Medicine/Primary Care Article Source Type: news

Hydrocodone Combination Products: New Written Rx Required Starting Today (Mon 10/6)
Miscommunication and misinterpretation by DEA, states, and insurance companies of new rules to restrict prescriptions for hydrocodone combination products (mostly hydrocodone/acetaminophen) are leaving chronic pain patients confused and without their medicine. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 5, 2014 Category: Pharmaceuticals Authors: David Kroll Source Type: news

Today Is The Last Day For Current Refills Of Hydrocodone Combination Products (Sunday, October 5)
Miscommunication and misinterpretation by DEA, states, and insurance companies of new rules to restrict prescriptions for hydrocodone combination products (mostly hydrocodone/acetaminophen) are leaving chronic pain patients confused and without their medicine. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 5, 2014 Category: Pharmaceuticals Authors: David Kroll Source Type: news

Friday Feedback: The Painful Prescription
(MedPage Today) -- When is Vicodin really the best choice? (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - October 3, 2014 Category: Psychiatry Source Type: news

Hydrocodone rescheduling takes effect Oct. 6
Read the full story on MD Consult: Hydrocodone rescheduling takes effect Oct. 6 (Source: MD Consult: News: Top Stories)
Source: MD Consult: News: Top Stories - September 30, 2014 Category: Journals (General) Source Type: news

DEA Makes Vicodin, Some Other Pain Meds Harder to Get
(MedPage Today) -- The agency is ratcheting up the restrictions on opioid painkillers another notch. (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - September 27, 2014 Category: Psychiatry Source Type: news

How Will Rescheduling of Hydrocodone Combo Products Affect Your Practice?
On Oct. 6, the DEA will move hydrocodone combination products from Schedule III to Schedule II, so family physicians need to prepare their practices -- and their patients -- for the change. (Source: AAFP News)
Source: AAFP News - September 17, 2014 Category: Primary Care Source Type: news

FDA ignored expert objections and its own advisory panel and approved deadly new painkiller
(NaturalNews) Over the objections of its own advisory panel, the FDA has approved another killer drug which hit pharmacy shelves in March - a powerful new painkiller named Zohydro which is 10 times stronger than Vicodin. In approving the drug, the FDA ignored an overwhelming 11 to... (Source: NaturalNews.com)
Source: NaturalNews.com - September 13, 2014 Category: Consumer Health News Source Type: news

Extended-release hydrocodone: the devil in disguise or just misunderstood? - Schweighardt AE, Juba KM.
Opioid abuse in the United States increased significantly over the past decade, leading to opioid-related deaths. Approval of Zohydro ER, a product that lacks an abuse-deterrent formulation, has provoked media controversy and aggressive legislative action ... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - September 5, 2014 Category: Global & Universal Tags: Alcohol and Other Drugs Source Type: news

25 percent fewer opioid-related deaths in states allowing medical marijuana
On average, states allowing the medical use of marijuana have lower rates of deaths resulting from opioid analgesic overdoses than states without such laws. Opioid analgesics, such as OxyContin, Percocet and Vicodin, are prescribed for moderate to severe pain, and work by suppressing a person’s perception of pain. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - August 26, 2014 Category: Science Source Type: news

U.S. tightens access to some narcotic painkillers
New regulations will make Vicodin and other painkillers containing hydrocodone harder to get (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - August 22, 2014 Category: Consumer Health News Source Type: news

New Rules For Hydrocodone: What You Should Know
The #1 most prescribed drug, hydrocodone/acetaminophen combinations, are about to become more difficult for some to get. In an attempt to minimize abuse, will the change also affects patients with legitimate medical needs for the narcotic painkiller? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - August 22, 2014 Category: Pharmaceuticals Authors: David Kroll Source Type: news

DEA tightens rules on hydrocodone products
One person dies every 19 minutes from a prescription drug overdose in the United States. On Thursday, the Drug Enforcement Administration tried to combat this epidemic by saying it will tighten controls on hydrocodone products, some of the most commonly misused narcotic painkillers on the market. (Source: WDSU.com - Health)
Source: WDSU.com - Health - August 22, 2014 Category: Consumer Health News Source Type: news

DEA tightens rules on hydrocodone products
Hydrocodone combination pills, also known as opiods, have moved from a Schedule III drug to a Schedule II drug. (Source: CNN.com - Health)
Source: CNN.com - Health - August 22, 2014 Category: Consumer Health News Source Type: news

Morning Break: Ice Bucket Challenger Dies, Vicodin Now Schedule II
(MedPage Today) -- Health news and commentary from around the Web, gathered by the MedPage Today staff. (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - August 22, 2014 Category: Psychiatry Source Type: news

DEA tightens controls on hydrocodone painkiller drugs
The U.S. Drug Enforcement Administration is putting tighter controls on the nation's most widely prescribed narcotic painkiller in a move to stem an epidemic of addiction, overdose and death. (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - August 22, 2014 Category: Science Source Type: news

DEA Further Restricts Hydrocodone Combination ProductsDEA Further Restricts Hydrocodone Combination Products
The US Drug Enforcement Administration has voted to move forward with rescheduling hydrocodone combination products from schedule III to schedule II drugs, an act that will take effect in 45 days. Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - August 22, 2014 Category: Psychiatry Tags: Psychiatry News Source Type: news

Hydrocodone Products to Get More Severe, Schedule II Classification (FREE)
By Amy Orciari Herman Edited by André Sofair, MD, MPH Combination hydrocodone products, currently considered Schedule III drugs, will be reclassified as Schedule II because of their high risk for … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - August 22, 2014 Category: Primary Care Source Type: news

U.S. to tighten restrictions on common opioid painkillers
WASHINGTON (Reuters) - The U.S. government is tightening restrictions on hydrocodone, an opioid painkiller contained in Vicodin and other addictive drugs. (Source: Reuters: Health)
Source: Reuters: Health - August 22, 2014 Category: Consumer Health News Tags: healthNews Source Type: news

U.S. to Tighten Access to Certain Narcotic Painkillers
Drugs containing hydrocodone, which include Vicodin, would be affected (Source: WebMD Health)
Source: WebMD Health - August 22, 2014 Category: Consumer Health News Source Type: news

D.E.A. Increases Restrictions on Prescription Painkillers Like Vicodin
To tackle prescription drug abuse, new rules for dispensing hydrocodone, the most widely prescribed painkiller in the United States, include no phoned-in prescriptions and no refills. (Source: NYT Health)
Source: NYT Health - August 21, 2014 Category: Consumer Health News Authors: By SABRINA TAVERNISE Tags: Drug Enforcement Administration Pain-Relieving Drugs Katz, Nathaniel Drug Abuse and Traffic Source Type: news

In Move to Curb Drug Abuse, D.E.A. Tightens Rule on Widely Prescribed Painkiller
New rules for dispensing hydrocodone, the most widely prescribed painkiller in the United States, include no phoned-in prescriptions and no refills. (Source: NYT Health)
Source: NYT Health - August 21, 2014 Category: Consumer Health News Authors: By SABRINA TAVERNISE Tags: Drug Enforcement Administration Pain-Relieving Drugs Katz, Nathaniel Drug Abuse and Traffic Source Type: news

Update on Tamper-Proof Hydrocodone ProductsUpdate on Tamper-Proof Hydrocodone Products
Purdue and Zogenix report their progress in gaining approval for formulations of single-entity hydrocodone bitartrate that are difficult to misuse or abuse. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 9, 2014 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Purdue’s hydrocodone bitartrate tablets granted priority review designation
Purdue Pharma has been granted priority review designation by the US Food and Drug Administration (FDA) for its hydrocodone bitartrate extended-release tablets for treatment of chronic pain. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - July 9, 2014 Category: Pharmaceuticals Source Type: news

Must-read: the approval of Zohydro, and more tox on the web
Must-read of the week: Stephen S. Hall’s article “How Much Does It Hurt?” in the current edition of  New York magazine gives the best explanation I’ve seen of how the Food and Drug Administration ended up approving the extended-release hydrocodone product ZohydroER, even though their scientific advisory committee recommended against approval by a vote of 11-2. According to the article, Dr. Robert Rappaport, Director of the FDA’s Anesthesia, analgesia, and Addiction Products section, “reminded that advisory committee that it had to consider the Zohydro application within the nar...
Source: The Poison Review - June 16, 2014 Category: Toxicology Authors: Leon Tags: Medical ayahuasca FDA new york magazine zohydro Source Type: news

Drug users switch to heroin because it's cheap, easy to get
Drug users are attracted to heroin not only for the “high,” but because it is less expensive and easier to get than prescription painkillers, a nationwide survey of heroin users indicate. Researchers have found that many suburban drug users have made the switch. "In the past, heroin was a drug that introduced people to narcotics," said the principal investigator. "But what we're seeing now is that most people using heroin begin with prescription painkillers such as OxyContin, Percocet or Vicodin, and only switch to heroin when their prescription drug habits get too expensive." (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 28, 2014 Category: Science Source Type: news

Report: More than 300K seniors addicted to prescription drugs
Drugs include narcotic painkillers such as Percocet, Vicodin and anti-anxiety medicines like Xanax, Valium (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - May 21, 2014 Category: Consumer Health News Source Type: news

Methanol poisoning disaster in Kenya, and other tox on the web
Walking Dead Man: KDFW-TV in Dallas-fort Worth  is reporting that the synthetic cannabinoid responsible for sending at least 140 people to hospital in D-FW and Austin was packaged with the labels “Dead Man Walking” and “Walking Dead Man.” Signs and symptoms included psychosis, aggressive behavior, blackouts, and hyperthermia. You can read TPR‘s coverage of this outbreak here. 25I-NBOMe in Virginia: The CBS affiliate WUSA-TV in Washington D.C. recently reported that they were seeing more cases of intoxication from the psychedelic phenethylamine 25I-NBOMe. In one weekend last mont...
Source: The Poison Review - May 14, 2014 Category: Toxicology Authors: Leon Tags: Medical 25I-NBOMe canthardin groopman kenya liquid nitrogen poisoning methanol narcotic new leaf opiate opioids sapwell spanish fly synthetic cannabinoid toxic cocktail walking dead man Source Type: news

Novel Hydrocodone: 24-Hour Analgesia, Less Abuse PotentialNovel Hydrocodone: 24-Hour Analgesia, Less Abuse Potential
Once-daily, extended-release hydrocodone bitartrate provides persistent pain relief in patients with chronic nonmalignant and nonneuropathic pain and also comes with abuse-deterrent properties. Medscape Medical News (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - May 2, 2014 Category: Emergency Medicine Tags: Neurology & Neurosurgery News Source Type: news